Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 379

1.

Postoperative abdominal adhesions and bowel obstruction. A survey among Dutch general practitioners.

Leclercq RM, Van Barneveld KW, Schreinemacher MH, Assies R, Twellaar M, Bouvy ND, Muris JW.

Eur J Gen Pract. 2015;21(3):176-82. doi: 10.3109/13814788.2015.1055466. Epub 2015 Jul 10.

PMID:
26161685
2.

In vitro activity of josamycin against Streptococcus pyogenes isolated from patients with upper respiratory tract infections in France.

Auzou M, Caillon J, Poyart C, Weber P, Ploy MC, Leclercq R, Cattoir V.

Med Mal Infect. 2015 Jul;45(7):293-6. doi: 10.1016/j.medmal.2015.04.009. Epub 2015 Jun 6.

PMID:
26055628
3.

Unique blood culture for diagnosis of bloodstream infections in emergency departments: a prospective multicentre study.

Dargère S, Parienti JJ, Roupie E, Gancel PE, Wiel E, Smaiti N, Loiez C, Joly LM, Lemée L, Pestel-Caron M, du Cheyron D, Verdon R, Leclercq R, Cattoir V; UBC study group.

Clin Microbiol Infect. 2014 Nov;20(11):O920-7. doi: 10.1111/1469-0691.12656. Epub 2014 Jun 14.

4.

Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing.

Skurnik D, Roux D, Cattoir V, Danilchanka O, Lu X, Yoder-Himes DR, Han K, Guillard T, Jiang D, Gaultier C, Guerin F, Aschard H, Leclercq R, Mekalanos JJ, Lory S, Pier GB.

Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20747-52. doi: 10.1073/pnas.1221552110. Epub 2013 Nov 18.

5.

Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes.

Marcadé G, Micol JB, Jacquier H, Raskine L, Donay JL, Nicolas-Viaud S, Rouveau M, Ribaud P, Dombret H, Leclercq R, Cambau E.

J Antimicrob Chemother. 2014 Feb;69(2):500-5. doi: 10.1093/jac/dkt376. Epub 2013 Oct 3.

PMID:
24092659
6.

Genetic basis for in vitro and in vivo resistance to lincosamides, streptogramins A, and pleuromutilins (LSAP phenotype) in Enterococcus faecium.

Isnard C, Malbruny B, Leclercq R, Cattoir V.

Antimicrob Agents Chemother. 2013 Sep;57(9):4463-9. doi: 10.1128/AAC.01030-13. Epub 2013 Jul 8.

7.

The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice.

Schlusselhuber M, Torelli R, Martini C, Leippe M, Cattoir V, Leclercq R, Laugier C, Grötzinger J, Sanguinetti M, Cauchard J.

Antimicrob Agents Chemother. 2013 Oct;57(10):4615-21. doi: 10.1128/AAC.02044-12. Epub 2013 Jul 1.

8.

Lincosamide resistance mediated by lnu(C) (L phenotype) in a Streptococcus anginosus clinical isolate.

Gravey F, Galopin S, Grall N, Auzou M, Andremont A, Leclercq R, Cattoir V.

J Antimicrob Chemother. 2013 Nov;68(11):2464-7. doi: 10.1093/jac/dkt255. Epub 2013 Jun 27.

PMID:
23812683
9.

Aspergillus vertebral osteomyelitis in immunocompetent subjects: case report and review of the literature.

Nicolle A, de la Blanchardière A, Bonhomme J, Hamon M, Leclercq R, Hitier M.

Infection. 2013 Aug;41(4):833-40. doi: 10.1007/s15010-013-0463-6. Epub 2013 Apr 28. Review.

PMID:
23625788
10.

Changes in enterococcal populations and related antibiotic resistance along a medical center-wastewater treatment plant-river continuum.

Leclercq R, Oberlé K, Galopin S, Cattoir V, Budzinski H, Petit F.

Appl Environ Microbiol. 2013 Apr;79(7):2428-34. doi: 10.1128/AEM.03586-12. Epub 2013 Feb 1.

11.

Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?

Cattoir V, Leclercq R.

J Antimicrob Chemother. 2013 Apr;68(4):731-42. doi: 10.1093/jac/dks469. Epub 2012 Dec 2. Review.

PMID:
23208830
12.

Microbiological investigation and clinical significance of Corynebacterium spp. in respiratory specimens.

Nhan TX, Parienti JJ, Badiou G, Leclercq R, Cattoir V.

Diagn Microbiol Infect Dis. 2012 Nov;74(3):236-41. doi: 10.1016/j.diagmicrobio.2012.07.001. Epub 2012 Aug 29.

PMID:
22938828
13.

AsrR is an oxidative stress sensing regulator modulating Enterococcus faecium opportunistic traits, antimicrobial resistance, and pathogenicity.

Lebreton F, van Schaik W, Sanguinetti M, Posteraro B, Torelli R, Le Bras F, Verneuil N, Zhang X, Giard JC, Dhalluin A, Willems RJ, Leclercq R, Cattoir V.

PLoS Pathog. 2012;8(8):e1002834. doi: 10.1371/journal.ppat.1002834. Epub 2012 Aug 2.

14.

Analysis of borderline oxacillin-resistant Staphylococcus aureus (BORSA) strains isolated in Tunisia.

Maalej SM, Rhimi FM, Fines M, Mnif B, Leclercq R, Hammami A.

J Clin Microbiol. 2012 Oct;50(10):3345-8. doi: 10.1128/JCM.01354-12. Epub 2012 Jul 18.

15.

Galleria mellonella as a model for studying Enterococcus faecium host persistence.

Lebreton F, Le Bras F, Reffuveille F, Ladjouzi R, Giard JC, Leclercq R, Cattoir V.

J Mol Microbiol Biotechnol. 2011;21(3-4):191-6. doi: 10.1159/000332737. Epub 2012 Jan 31.

PMID:
22286046
16.

Emergence of Staphylococcus aureus strains resistant to pristinamycin in Sfax (Tunisia).

Mezghani Maalej S, Malbruny B, Leclercq R, Hammami A.

Pathol Biol (Paris). 2012 Dec;60(6):e71-4. doi: 10.1016/j.patbio.2011.10.012. Epub 2012 Jan 20.

PMID:
22265593
17.

In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment.

Schlusselhuber M, Jung S, Bruhn O, Goux D, Leippe M, Leclercq R, Laugier C, Grötzinger J, Cauchard J.

Antimicrob Agents Chemother. 2012 Apr;56(4):1749-55. doi: 10.1128/AAC.05797-11. Epub 2012 Jan 9.

18.

EUCAST expert rules in antimicrobial susceptibility testing.

Leclercq R, Cantón R, Brown DF, Giske CG, Heisig P, MacGowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, Soussy CJ, Steinbakk M, Winstanley TG, Kahlmeter G.

Clin Microbiol Infect. 2013 Feb;19(2):141-60. doi: 10.1111/j.1469-0691.2011.03703.x. Epub 2011 Nov 25. Review.

19.

Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia.

Gac AC, Parienti JJ, Chantepie S, Fradin S, Le Coutour X, Leclercq R, Reman O.

Leuk Res. 2011 Oct;35(10):1294-6. doi: 10.1016/j.leukres.2011.05.035. Epub 2011 Aug 9.

PMID:
21831426
20.

D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium.

Lebreton F, Depardieu F, Bourdon N, Fines-Guyon M, Berger P, Camiade S, Leclercq R, Courvalin P, Cattoir V.

Antimicrob Agents Chemother. 2011 Oct;55(10):4606-12. doi: 10.1128/AAC.00714-11. Epub 2011 Aug 1.

21.

In vitro activity of new antimicrobial agents against glycopeptide-resistant Enterococcus faecium clinical isolates from France between 2006 and 2008.

Bérenger R, Bourdon N, Auzou M, Leclercq R, Cattoir V.

Med Mal Infect. 2011 Aug;41(8):405-9. doi: 10.1016/j.medmal.2010.12.013. Epub 2011 May 7. Review.

PMID:
21550192
22.

Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis.

Parienti JJ, Cattoir V, Thibon P, Lebouvier G, Verdon R, Daubin C, du Cheyron D, Leclercq R, Charbonneau P.

J Hosp Infect. 2011 Jun;78(2):118-22. doi: 10.1016/j.jhin.2011.03.008. Epub 2011 Apr 16.

PMID:
21497946
23.

Rapid and efficient detection of Mycobacterium tuberculosis in respiratory and non-respiratory samples.

Malbruny B, Le Marrec G, Courageux K, Leclercq R, Cattoir V.

Int J Tuberc Lung Dis. 2011 Apr;15(4):553-5. doi: 10.5588/ijtld.10.0497.

PMID:
21396219
24.

Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08.

Bourdon N, Fines-Guyon M, Thiolet JM, Maugat S, Coignard B, Leclercq R, Cattoir V.

J Antimicrob Chemother. 2011 Apr;66(4):713-21. doi: 10.1093/jac/dkq524. Epub 2011 Jan 28.

PMID:
21393182
25.

In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

Lascols C, Legrand P, Mérens A, Leclercq R, Muller-Serieys C, Drugeon HB, Kitzis MD, Reverdy ME, Roussel-Delvallez M, Moubareck C, Brémont S, Miara A, Gjoklaj M, Soussy CJ.

Int J Antimicrob Agents. 2011 Mar;37(3):235-9. doi: 10.1016/j.ijantimicag.2010.11.035. Epub 2011 Feb 4.

26.

Cross-resistance to lincosamides, streptogramins A, and pleuromutilins due to the lsa(C) gene in Streptococcus agalactiae UCN70.

Malbruny B, Werno AM, Murdoch DR, Leclercq R, Cattoir V.

Antimicrob Agents Chemother. 2011 Apr;55(4):1470-4. doi: 10.1128/AAC.01068-10. Epub 2011 Jan 18. Erratum in: Antimicrob Agents Chemother. 2011 Jun;55(6):3065.

27.

Prevalence of toxin genes in consecutive clinical isolates of Staphylococcus aureus and clinical impact.

Nhan TX, Leclercq R, Cattoir V.

Eur J Clin Microbiol Infect Dis. 2011 Jun;30(6):719-25. doi: 10.1007/s10096-010-1143-4. Epub 2011 Jan 12.

PMID:
21225304
28.

Low carriage of vancomycin-resistant enterococci in the digestive tract of French hospitalised patients: a nationwide prospective study in 2006.

Fortineau N, Bourdon N, Leclercq R, Vachée A, Delarbre JM, Maugat S, Robert J; ONERBA.

J Hosp Infect. 2011 Feb;77(2):179-81. doi: 10.1016/j.jhin.2010.10.001. Epub 2011 Jan 7. No abstract available.

PMID:
21216037
29.

Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus saprophyticus clinical isolates.

Le Bouter A, Leclercq R, Cattoir V.

Int J Antimicrob Agents. 2011 Feb;37(2):118-23. doi: 10.1016/j.ijantimicag.2010.10.008. Epub 2010 Dec 24.

PMID:
21185697
30.

[Enterococci resistant to glycopeptides].

Cattoir V, Leclercq R.

Med Sci (Paris). 2010 Nov;26(11):936-42. doi: 10.1051/medsci/20102611936. French.

31.

In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

Lascols C, Legrand P, Mérens A, Leclercq R, Armand-Lefevre L, Drugeon HB, Kitzis MD, Muller-Serieys C, Reverdy ME, Roussel-Delvallez M, Moubareck C, Lemire A, Miara A, Gjoklaj M, Soussy CJ.

Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):475-82. doi: 10.1007/s10096-010-1117-6. Epub 2010 Nov 19. Review.

32.

Comparison of four methods, including semi-automated rep-PCR, for the typing of vancomycin-resistant Enterococcus faecium.

Bourdon N, Lemire A, Fines-Guyon M, Auzou M, Périchon B, Courvalin P, Cattoir V, Leclercq R.

J Microbiol Methods. 2011 Jan;84(1):74-80. doi: 10.1016/j.mimet.2010.10.014. Epub 2010 Nov 6.

PMID:
21062634
33.

[Vancomycin, what else?].

Daurel C, Leclercq R.

Arch Pediatr. 2010 Sep;17 Suppl 4:S121-8. doi: 10.1016/S0929-693X(10)70912-X. French.

PMID:
20826319
34.

Rapid detection of vancomycin-resistant enterococci from rectal swabs by the Cepheid Xpert vanA/vanB assay.

Bourdon N, Bérenger R, Lepoultier R, Mouet A, Lesteven C, Borgey F, Fines-Guyon M, Leclercq R, Cattoir V.

Diagn Microbiol Infect Dis. 2010 Jul;67(3):291-3. doi: 10.1016/j.diagmicrobio.2010.02.009.

PMID:
20542208
35.

Factors associated with emergence of pristinamycin-resistant Staphylococcus aureus in a dermatology department: a case-control study.

Verneuil L, Marchand C, Vidal JS, Ze Bekolo R, Daurel C, Lebouvier G, Leroy D, Leclercq R.

Br J Dermatol. 2010 Aug;163(2):329-33. doi: 10.1111/j.1365-2133.2010.09826.x. Epub 2010 Apr 26.

PMID:
20426786
36.

Genome sequence of Streptococcus gallolyticus: insights into its adaptation to the bovine rumen and its ability to cause endocarditis.

Rusniok C, Couvé E, Da Cunha V, El Gana R, Zidane N, Bouchier C, Poyart C, Leclercq R, Trieu-Cuot P, Glaser P.

J Bacteriol. 2010 Apr;192(8):2266-76. doi: 10.1128/JB.01659-09. Epub 2010 Feb 5.

37.

Multilocus sequence analysis for typing Leptospira interrogans and Leptospira kirschneri.

Leon A, Pronost S, Fortier G, Andre-Fontaine G, Leclercq R.

J Clin Microbiol. 2010 Feb;48(2):581-5. doi: 10.1128/JCM.00543-09. Epub 2009 Dec 2.

38.

Escherichia coli as reservoir for macrolide resistance genes.

Phuc Nguyen MC, Woerther PL, Bouvet M, Andremont A, Leclercq R, Canu A.

Emerg Infect Dis. 2009 Oct;15(10):1648-50. doi: 10.3201/eid1510.090696.

39.

Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy.

Daurel C, Fiant AL, Brémont S, Courvalin P, Leclercq R.

Antimicrob Agents Chemother. 2009 Nov;53(11):4953-4. doi: 10.1128/AAC.01592-08. Epub 2009 Sep 8. No abstract available.

40.

Trimethoprim resistance genes in vancomycin-resistant Enterococcus faecium clinical isolates from France.

Cattoir V, Huynh TM, Bourdon N, Auzou M, Leclercq R.

Int J Antimicrob Agents. 2009 Oct;34(4):390-2. doi: 10.1016/j.ijantimicag.2009.06.013. Epub 2009 Jul 19. No abstract available.

PMID:
19619988
41.

Influence of recombination on development of mutational resistance to linezolid in Enterococcus faecalis JH2-2.

Boumghar-Bourtchaï L, Dhalluin A, Malbruny B, Galopin S, Leclercq R.

Antimicrob Agents Chemother. 2009 Sep;53(9):4007-9. doi: 10.1128/AAC.01633-08. Epub 2009 Jun 22.

42.

A chromosomal chloramphenicol acetyltransferase determinant from a probiotic strain of Bacillus clausii.

Galopin S, Cattoir V, Leclercq R.

FEMS Microbiol Lett. 2009 Jun;296(2):185-9. doi: 10.1111/j.1574-6968.2009.01633.x. Epub 2009 Apr 30.

43.

Resistance to macrolides by ribosomal mutation in clinical isolates of Turicella otitidis.

Boumghar-Bourtchai L, Chardon H, Malbruny B, Mezghani S, Leclercq R, Dhalluin A.

Int J Antimicrob Agents. 2009 Sep;34(3):274-7. doi: 10.1016/j.ijantimicag.2009.03.023. Epub 2009 May 2.

PMID:
19414240
44.

Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.

Leclercq R.

Clin Microbiol Infect. 2009 Mar;15(3):224-31. doi: 10.1111/j.1469-0691.2009.02739.x. Review.

45.

Emergence and spread of vancomycin resistance among enterococci in Europe.

Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, Klare I, Kristinsson KG, Leclercq R, Lester CH, Lillie M, Novais C, Olsson-Liljequist B, Peixe LV, Sadowy E, Simonsen GS, Top J, Vuopio-Varkila J, Willems RJ, Witte W, Woodford N.

Euro Surveill. 2008 Nov 20;13(47). pii: 19046. Review.

46.

Prevalence and risk factors of the whole spectrum of sexually transmitted diseases in male incoming prisoners in France.

Verneuil L, Vidal JS, Ze Bekolo R, Vabret A, Petitjean J, Leclercq R, Leroy D.

Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):409-13. doi: 10.1007/s10096-008-0642-z. Epub 2008 Nov 8.

PMID:
18998176
47.

Healthcare-associated infections: think globally, act locally.

Marcel JP, Alfa M, Baquero F, Etienne J, Goossens H, Harbarth S, Hryniewicz W, Jarvis W, Kaku M, Leclercq R, Levy S, Mazel D, Nercelles P, Perl T, Pittet D, Vandenbroucke-Grauls C, Woodford N, Jarlier V.

Clin Microbiol Infect. 2008 Oct;14(10):895-907. doi: 10.1111/j.1469-0691.2008.02074.x. Review.

48.

Prevalence of high-level vancomycin-resistant enterococci in French broilers and pigs.

Kempf I, Hellard G, Perrin-Guyomard A, Gicquel-Bruneau M, Sanders P, Leclercq R.

Int J Antimicrob Agents. 2008 Nov;32(5):463-4. doi: 10.1016/j.ijantimicag.2008.04.029. Epub 2008 Aug 13. No abstract available.

PMID:
18703316
49.

Macrolide-resistant Shigella sonnei.

Boumghar-Bourtchai L, Mariani-Kurkdjian P, Bingen E, Filliol I, Dhalluin A, Ifrane SA, Weill FX, Leclercq R.

Emerg Infect Dis. 2008 Aug;14(8):1297-9. doi: 10.3201/eid1408.080147.

50.

[Vancomycin-resistant enterococci: ONERBA networks data and results of the national 2006 survey on digestive carriage].

Fortineau N, Leclercq R, Maugat S, Robert J; Conseil Scientifique de l'ONERBA.

Med Mal Infect. 2008 Jun;38 Suppl 2:S65-7. doi: 10.1016/S0399-077X(08)72995-0. French. No abstract available.

PMID:
18598874

Supplemental Content

Loading ...
Support Center